Helicore, LLC

SOUTHBURY, CT · Founded 2020 · CIK 0001810144 · Biotech · Private

Long-acting antibody conjugates for quarterly-dosed therapeutics

helicore.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$2.0M
1 Form D · Apr 2020
77 months since last filing
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$2,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2368Propagenix Inc—$2.3M
2369Merida Biosciences——
23703D HEALTH SOLUTIONS, INC.——
2371Helicore, LLC—$2.0M
2372IMMUNE-ONC THERAPEUTICS, INC.—$7.0M
2373Eluciderm Inc.—$3.8M
2374BIO-PATH HOLDINGS, INC.—$18M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Charles BridgeDirector
  • Joshua DotsonDirector
  • Waters KelloggDirector
  • Holger KoehlerDirector
  • Kevin RussDirector · Executive Officer
  • Lucas TurnerDirector

Patents

USPTO · 0 granted of 1
  • Helical Anchor Foundation Systemapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.